We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Xaar Plc | LSE:XAR | London | Ordinary Share | GB0001570810 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
6.00 | 5.36% | 118.00 | 115.00 | 118.50 | 118.00 | 117.50 | 117.50 | 61,804 | 13:59:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Commercial Printing, Nec | 72.78M | 1.63M | 0.0208 | 56.73 | 92.73M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/8/2021 14:58 | Thanks for that explanation mrnumpty. As a recent subscriber I have been wondering what nap meant. There doesn't seem to be anywhere on the website to find this sort of thing out? | bull19 | |
11/8/2021 11:40 | I bought in to Xaar this morning . Correction to my post here yesterday : SCSW has Xaar as a second-half Nap ( ie a Napoleon , as in card playing , or a trump card ) ; the magazine did not actually indicate that it might put Xaar in the Growth Portfolio 3 . Good luck all . | mrnumpty | |
11/8/2021 11:16 | Yes 25m pounds apologies Breaking out now won’t surprise to see it spike to 320 | nobilis | |
11/8/2021 10:58 | >>Stratsys 33m pound news soon>> 33 million dollars, I think. | zho | |
11/8/2021 10:54 | If I fancy a SCSW tip I usually just bite the bullet and buy in on day one and add along the way if it performs well. Think you can download a free copy of SCSW from their site if anyone wants to have a look. It’ll probably be the April or May edition. | dil 21 | |
11/8/2021 09:48 | Xar on move up Stratsys 33m pound news soon | nobilis | |
11/8/2021 07:03 | Of about 30 that I have traded I’ve had upgs/calnex/reach/jo The scsw picks are better than my own I have to like the company and have a basic grasp of what they do. After that I don’t really look to closely at most of them perhaps a handful that I follow more closely. | dr biotech | |
11/8/2021 02:09 | Some really good advice there. Thank you dougmachin. I did forget to mention john Menzies (hasn't moved much yet, so forgot to mention). I'm long in that one too and hopeful on it. Didn't go long ATG when i looked at revenue, losses and price\sales ratio (if i compare ATG to made.com (for example) i much prefer made.com). Reach and MADE are now my favourite 2 stocks. I can't stop myself keep buying more made.com every day (at these levels). At the end of every trading day i say to myself "you've got enough now" and then i go and buy more the next day!Sorry also for going off topic. Will follow your advice (checking for gp3, checking for * and cross checking against other info sources). | simmsc | |
11/8/2021 00:56 | I normally only buy: - SCSW Growth Portfolio stocks. - Ones where the SCSW writer (editor) has a declared holding (normally has an * at the end of the write-up). This is different to the just "we're buyers". - Where directors are buying heavily or there's a significant buy back, like TRMR. - Where there's a bigger picture growth story, like RCH, VLX, MNZS, ATG (didn't see this with Esken) or KMK (which SCSW actually gave up on). - Where other experienced investors (PiWorld / following on Twitter / Mello presentations / IC etc etc) are kind of cross correlating the story. - Go in smaller at the start and then buy the dips if the story seems to get better, maybe at a higher price. There always seems to be significant dips. Apologies for off topic and I am far from good at this, but this seems to be working for me, so far! I first subscribed to SCSW about 16 years ago (with HSP the first time around). | dougmachin | |
10/8/2021 21:40 | I've noticed that dr biotech and i have been drawn to some of the dud ones that scsw has recommended. I'm up on Volex, just cut my losses yesterday on esken (much bigger loss in on esken than i have profit on Volex). Luckily i gave Heiq a miss (i almost bought some of those). Overall I'm losing on SCSW tips. I have a much bigger position in Reach (but reach was recommended to me before scsw recommended it, so i can't credit them for that one). | simmsc | |
10/8/2021 16:32 | The only two stocks not to perform Just buy everything and the overall result is explosive profits | nw99 | |
10/8/2021 15:32 | Dr biotech . Thanks for the pleasant reply . As others have said , the “ buy “ tips by SCSW are not fool-proof ( but then we’d all instantly become rich , and wouldn’t that be boring ?!? ) . However I’ve found SCSW to be FAR better than Investors’ Chronicle , to which I’ve just stopped my subscription . I’ve learnt to pay especial attention to the shares which SCSW puts in to its Growth Portfolio ( GP3 now ) . Without having the magazine immediately l in front of me , I believe the editor stated on the back page ( page 8 ) that he wants to put Xaar in GP3 . I wasn’t at all surprised by the instant 10% mark-up in the price of Xaar on Monday morning - I’m watching on the sidelines in the hope that it will ( momentarily ! ) relinquish some of that price leap . Good luck | mrnumpty | |
10/8/2021 12:46 | Well,that's where they made money and the share price exceeded £10. Let's wait for more encouraging news. However, China is risky and they can and do change the rules. I'm sure Xaar will diversify their global activity. | farmergeorge | |
10/8/2021 12:23 | Looks like they are really going for it in China | nobilis | |
10/8/2021 12:18 | Thank's for the link nobilis. Very encouraging. | farmergeorge | |
10/8/2021 12:03 | The tips are not bullet proof. You need to read the research and do you own DD. You will always get losers. Practice risk management and you'll do well over the long term | essential | |
10/8/2021 11:41 | I’ve only been a subscriber for 14months - just seemed to be getting harder. I accept your greater history though. I've bought some that never dropped back but others have. recently I’ve bought in two lumps to mitigate this. While most have done well there have been quite a few duff picks too, my two biggest losers over the last year are Esken and Argentex. The latter may recover, think the former will struggle. | dr biotech | |
10/8/2021 11:30 | Agreed you are correct | nw99 | |
10/8/2021 11:30 | It's always been like that from the start nothing wrong with the mms marking it up | nw99 | |
10/8/2021 11:13 | drbiotech . With respect it's not that Small Company Share Watch " has become too popular " ( thereby causing market makers to bump up prices before the markets even open . As someone who has been a subscriber to SCSW for maybe a decade , I can confirm that this has always been the case during that period , so I've learnt to watch and wait after a " buy " tip . It's a great publication and I've just started a subscription to its " sister " ( brother ? ) magazine , the Momentum Investor , and I'll see how that goes before I consider buying any of their tips . Good luck all . | mrnumpty | |
10/8/2021 10:59 | Often drops back a few days after the tip. Like the 2 added to their portfolio in July, before gaining more later as the story unfolds | darrenp746 | |
10/8/2021 09:07 | I’ve taken a small position purely on the back of the tip. If it drops back to last weeks prices I’ll add some more. Scsw has become a bit too popular, often the starting price is 10% above the tip | dr biotech | |
09/8/2021 15:18 | Won’t surprise if news this week | nobilis |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions